How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market
- By Microbial Type: Bacterial Inoculants, Fungal Biocontrol Agents, Viral Biopesticides, Protozoan Biocontrol Agents, Other Microbial Agents
- By Application: Biofertilizers, Biopesticides, Plant Growth Promoters, Soil Conditioners, Post-harvest Disease Control
- By Crop Type: Cereals and Grains, Fruits and Vegetables, Oilseeds and Pulses, Turf and Ornamentals, Plantations and Perennials
- By Formulation Type: Wettable Powders, Granules, Suspension Concentrates, Emulsifiable Concentrates, Dry Powders
- By Mode of Action: Nitrogen Fixation, Pathogen Antagonism, Induced Systemic Resistance, Nutrient Solubilization, Herbicidal Activity
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Bacterial Inoculants leads By Microbial Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Microbial Type 5
Application 5
Crop Type 5
Formulation Type 5
Mode of Action 5
Companies profiled
Bayer CropScience
Syngenta (ChemChina)
BASF SE
Corteva Agriscience
Marrone Bio Innovations
Novozymes
Valent BioSciences
Certis USA
Koppert Biological Systems
Andermatt Biocontrol
Biocontrol Technologies
Lallemand Plant Care
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bayer CropScience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Syngenta (ChemChina)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Corteva Agriscience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Marrone Bio Innovations
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Novozymes
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Valent BioSciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Certis USA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Koppert Biological Systems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Andermatt Biocontrol
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Biocontrol Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Lallemand Plant Care
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Isagro S.p.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Valent U.S.A. LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →AgBiome
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,747M by 2033 · 7.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Bacterial Inoculants35.9
- Fungal Biocontrol Agents17.6
- Viral Biopesticides21.9
- Protozoan Biocontrol Agents9.4
- Other Microbial Agents15.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$506.5M → $995.2M · 8.8%
Europe$353.0M → $672.1M · 8.4%
Asia Pacific$322.3M → $542.8M · 6.7%
Latin America$199.5M → $329.3M · 6.5%
Middle East and Africa$153.5M → $245.2M · 6.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.502026
7.522027
7.522028
7.532029
7.542030
7.562031
7.572032
7.592033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bayer CropScience10.2
- Syngenta (ChemChina)15.6
- BASF SE6.3
- Corteva Agriscience11.5
- Marrone Bio Innovations13.8
- Novozymes14.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Microbial Type26.6%
Application35.1%
Crop Type16.5%
Formulation Type11.0%
Mode of Action10.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.7
- Europe24.1
- Asia Pacific19.5
- Latin America11.8
- Middle East and Africa8.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bayer CropScience | 94 | 95 | 74 | 99 | 82 | 87 | 89 |
| Syngenta (ChemChina) | 72 | 76 | 89 | 90 | 89 | 88 | 84 |
| BASF SE | 86 | 64 | 65 | 65 | 78 | 67 | 71 |
| Corteva Agriscience | 79 | 80 | 79 | 79 | 80 | 68 | 78 |
| Marrone Bio Innovations | 76 | 54 | 55 | 60 | 59 | 63 | 61 |
| Novozymes | 62 | 62 | 48 | 54 | 59 | 60 | 58 |
| Valent BioSciences | 63 | 63 | 47 | 60 | 41 | 47 | 54 |
| Certis USA | 52 | 52 | 51 | 35 | 40 | 45 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bayer CropScience
- Syngenta (ChemChina)
- BASF SE
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bayer CropScience | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Syngenta (ChemChina) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| BASF SE | ◐ | − | ◐ | ◐ | ✓ | ✓ |
| Corteva Agriscience | ✓ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Marrone Bio Innovations | ◐ | − | ◐ | ◐ | ◐ | ◐ |
| Novozymes | − | ◐ | ◐ | − | − | ✓ |
| Valent BioSciences | ◐ | ◐ | − | − | − | ◐ |
| Certis USA | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bayer CropScience89
2Syngenta (ChemChina)84
3Corteva Agriscience78
4BASF SE71
5Marrone Bio Innovations61
6Novozymes58
7Valent BioSciences54
8Certis USA46
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Bayer CropScienceSyngenta (ChemChina)Corteva Agriscience
Challenger1
Strong scale, closing on the leaders.
BASF SE
Contender2
Focused players with pockets of strength.
Marrone Bio InnovationsNovozymes
Niche2
Specialists in a single segment or region.
Valent BioSciencesCertis USA
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Microbial Type in North America, then scale across Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market — a $236M beachhead inside a $4.21B market.
Beachhead (SOM)$236Mobtainable near-term
Serviceable (SAM)$1.55Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Bacterial Inoculants
Best fit — highest urgency & budget in Microbial Type.
Economic buyer77 fit
Fungal Biocontrol Agents
Strong fit — clear ROI and a fast path to value.
End user65 fit
Viral Biopesticides
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Microbial Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Crop Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve24%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Microbial Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified24%
Evaluation12%
Closed-won6%
$14.1KCAC
$73KLTV
5.2:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market is a resilient opportunity — $4.98B by 2033, compounding at 4.3%.
TAM · 2025$3.56Btoday
TAM · 2033$4.98Bforecast
CAGR4.3%2027–2033
Cumulative$38.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.98BTotal addressable market
SAM$2.03BServiceable available market
SOM$446MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.3% CAGR
Demand compounds through 2033, outpacing GDP across Microbial Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Microbial Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.98BLarge & growingTAM by 2033 at 4.3% CAGR
$2.03BServiceable nowreachable with today’s model
$446MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.89BBear2.8% CAGR
$4.98BBase4.3% CAGR
$6.38BBull5.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market — a $5.34B market by 2033. Plan: grow share from 9.8% to 15.7%.
Market size · 2033$5.34Btotal addressable
Market CAGR3.7%2027–2033
Target share15.7%from 9.8% today
Revenue ambition$839Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.8% | 15.7% | At risk |
| Revenue | $476M | $839M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 34.2% | 41.3% | On track |
| Customer retention | 88.9% | 94.3% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Microbial Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Microbial Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $86M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Microbial Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market conversation — a $4.71B market you can size, segment and defend in minutes.
Market size · 2033$4.71Btotal opportunity
Growth9.5%CAGR to 2033
Addressable buyers1,474+accounts in scope
Typical ROI4.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Microbial Type
Goal Grow share in Microbial Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.2×return on cost, year one
< 2 mopayback period
$68K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Bayer CropScienceSyngenta (ChemChina)BASF SECorteva AgriscienceMarrone Bio InnovationsNovozymesValent BioSciencesCertis USA+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bacteria, Fungi, Virus, Protozoa and other Agricultural Microbials Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Bacterial & Viral Specimen Collection Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBacterial (Pyogenic) Meningitis Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportBacterial Biopesticide Market
Market size, share, segmentation and regional forecast.
$371M market · 2025 base year
View reportBacterial Colony Counters Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportBacterial Endotoxin & Fungal Glucan Tester Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBacterial FermentationBiosynthesisEnzymatic Catalysis Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportBacterial Filter Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportBacterial Pneumonia Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportBacterial Skin Diseases Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportBacterial vaginosis Market
Market size, share, segmentation and regional forecast.
$551M market · 2025 base year
View reportBactericidal Glass Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBacteriocides Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.